Cargando…

Development of a High-Accuracy, Low-Cost, and Portable Fluorometer with Smartphone Application for the Detection of Urinary Albumin towards the Early Screening of Chronic Kidney and Renal Diseases

This study presents the development of a portable fluorometer with a smartphone application designed to facilitate the early screening of chronic kidney and renal diseases by enabling the sensitive detection of urinary albumin. Utilizing a fluorescence-based aptasensor, the device achieved a linear...

Descripción completa

Detalles Bibliográficos
Autores principales: Pinrod, Visarute, Chawjiraphan, Wireeya, Segkhoonthod, Khoonsake, Hanchaisri, Kriangkai, Tantiwathanapong, Phornpol, Pinpradup, Preedee, Putnin, Thitirat, Pimalai, Dechnarong, Treerattrakoon, Kiatnida, Cha’on, Ubon, Anutrakulchai, Sirirat, Japrung, Deanpen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10526137/
https://www.ncbi.nlm.nih.gov/pubmed/37754110
http://dx.doi.org/10.3390/bios13090876
Descripción
Sumario:This study presents the development of a portable fluorometer with a smartphone application designed to facilitate the early screening of chronic kidney and renal diseases by enabling the sensitive detection of urinary albumin. Utilizing a fluorescence-based aptasensor, the device achieved a linear calibration curve (0.001–1.5 mg/mL) with a linearity of up to 0.98022 and a detection limit of 0.203 µg/mL for human serum albumin (HSA). The analysis of 130 urine samples demonstrated comparable performance between this study’s fluorometer, a commercial fluorometer, and the standard automated method. These findings validate the feasibility of the portable fluorometer and aptasensor combination as a reliable instrument for the sensitive and specific measurement of HSA in urine samples. Moreover, the fluorometer’s portability offers potential applications in portable point-of-care testing, enhancing its utility in clinical settings for early disease screening.